Hope for friedreich ataxia: Long-Term vatiquinone trial underway
NCT ID NCT05515536
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study looks at the long-term safety of the drug vatiquinone in 130 people with Friedreich ataxia who have already taken it in earlier studies. Researchers will track side effects and measure how the disease progresses over three years using a standard rating scale. The goal is to see if vatiquinone remains safe and may help control the condition over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CBR Neurogenetic Research Clinic, University of Auckland
Auckland, 1023, New Zealand
-
CHU Sainte-Justine
Montreal, Quebec, H3T1C5, Canada
-
Centre de Recherche du Centre Hospitalier de l'Université de Montreal (CRCHUM)
Montreal, Quebec, H2X 0A9, Canada
-
Department of Neurology and Hertie-Institute for Clinical Brain Research German Center of Neurodegenerative Diseases (DZNE)
Tübingen, 72076, Germany
-
Hospital Sant Joan de Déu Barcelona Unidad de Enfermedades Neuromusculares
Barcelona, 08950, Spain
-
Hôpital Pitié-Salpêtrière, Institut du Cerveau (Paris Brain Institute)
Paris, 75646, France
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
-
Ospedale Pediatrico Bambino Gesu' IRCCS
Roma, 00165, Italy
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
UCLA
Los Angeles, California, 90095, United States
-
University of Campinas (UNICAMP) - School of Medical Sciences, Dept of Neurology
São Paulo, 13083-887, Brazil
-
University of Florida
Gainesville, Florida, 32608, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of South Florida
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.